Two Sigma Investments’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37M | Buy |
2,161,697
+1,610,817
| +292% | +$27.5M | 0.07% | 351 |
|
|
2025
Q1 | $35.2M | Buy |
550,880
+475,826
| +634% | +$30.4M | 0.08% | 307 |
|
|
2024
Q4 | $9.13M | Sell |
75,054
-127,216
| -63% | -$15.5M | 0.02% | 755 |
|
|
2024
Q3 | $25.3M | Sell |
202,270
-339,524
| -63% | -$42.4M | 0.06% | 394 |
|
|
2024
Q2 | $85.6M | Buy |
541,794
+199,112
| +58% | +$31.5M | 0.2% | 114 |
|
|
2024
Q1 | $44.4M | Buy |
342,682
+40,342
| +13% | +$5.22M | 0.1% | 237 |
|
|
2023
Q4 | $29.2M | Sell |
302,340
-508,127
| -63% | -$49M | 0.07% | 307 |
|
|
2023
Q3 | $98.2M | Sell |
810,467
-478,731
| -37% | -$58M | 0.26% | 96 |
|
|
2023
Q2 | $148M | Buy |
1,289,198
+192,055
| +18% | +$22M | 0.37% | 57 |
|
|
2023
Q1 | $151M | Buy |
1,097,143
+405,737
| +59% | +$55.9M | 0.43% | 51 |
|
|
2022
Q4 | $89.6M | Sell |
691,406
-98,306
| -12% | -$12.7M | 0.28% | 85 |
|
|
2022
Q3 | $87.3M | Buy |
789,712
+759,045
| +2,475% | +$83.9M | 0.3% | 85 |
|
|
2022
Q2 | $2.3M | Sell |
30,667
-262,632
| -90% | -$19.7M | 0.01% | 1082 |
|
|
2022
Q1 | $22.9M | Sell |
293,299
-512,962
| -64% | -$40.1M | 0.07% | 347 |
|
|
2021
Q4 | $72.6M | Buy |
806,261
+553,885
| +219% | +$49.9M | 0.16% | 158 |
|
|
2021
Q3 | $23.3M | Buy |
252,376
+231,409
| +1,104% | +$21.4M | 0.05% | 359 |
|
|
2021
Q2 | $1.63M | Sell |
20,967
-65,300
| -76% | -$5.08M | ﹤0.01% | 1445 |
|
|
2021
Q1 | $6.43M | Buy |
+86,267
| New | +$6.43M | 0.02% | 736 |
|
|
2018
Q2 | – | Sell |
-56,203
| Closed | -$4.16M | – | 2345 |
|
|
2018
Q1 | $4.16M | Buy |
+56,203
| New | +$4.16M | 0.01% | 788 |
|
|
2017
Q1 | – | Sell |
-263,229
| Closed | -$7.22M | – | 2420 |
|
|
2016
Q4 | $7.22M | Buy |
+263,229
| New | +$7.22M | 0.03% | 578 |
|
|
2016
Q1 | – | Sell |
-115,518
| Closed | -$4.46M | – | 2342 |
|
|
2015
Q4 | $4.46M | Buy |
115,518
+26,251
| +29% | +$1.01M | 0.02% | 638 |
|
|
2015
Q3 | $2.87M | Buy |
+89,267
| New | +$2.87M | 0.01% | 649 |
|